UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin

American journal of physiology. Regulatory, integrative and comparative physiology, 1993-05, Vol.264 (5), p.917-R923

1993

Volltextzugriff (PDF)

Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis

Journal of lipid research, 1992-11, Vol.33 (11), p.1657-1663

1992

Volltextzugriff (PDF)

Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction

The Journal of pharmacology and experimental therapeutics, 1998-08, Vol.286 (2), p.611

1998

Volltextzugriff (PDF)

Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels

The Journal of pharmacology and experimental therapeutics, 1992-02, Vol.260 (2), p.437

1992

Volltextzugriff (PDF)

Pharmacological Characterization of a Novel Factor Xa Inhibitor, FXV673

Thrombosis research, 2001-08, Vol.103 (4), p.309-324

2001

Volltextzugriff (PDF)

Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells

American Journal of Physiology: Cell Physiology, 1991-04, Vol.260 (4), p.C721-C730

1991

Volltextzugriff (PDF)

Identification and Initial Structure−Activity Relationships of a Novel Class of Nonpeptide Inhibitors of Blood Coagulation Factor Xa

Journal of medicinal chemistry, 1998-02, Vol.41 (4), p.437-450

1998

Volltextzugriff (PDF)

RPR120844, a novel, specific inhibitor of coagulation factor Xa inhibits venous thrombosis in the rabbit

Thrombosis and haemostasis, 1999-01, Vol.81 (1), p.157-160

1999

Volltextzugriff (PDF)

In Vitro Characterization of a Novel Factor Xa Inhibitor, RPR 130737

Thrombosis research, 2000-07, Vol.99 (1), p.71-82

2000

Volltextzugriff (PDF)

Characterization and inhibition of 15-lipoxygenase in human monocytes: comparison with soybean 15-lipoxygenase

American Journal of Physiology: Cell Physiology, 1995-05, Vol.268 (5), p.C1301-C1307

1995

Volltextzugriff (PDF)

Inhibition of repetitive thrombus formation in the stenosed canine coronary artery by enoxaparin, but not by unfractionated heparin

Arteriosclerosis, thrombosis, and vascular biology, 1998-06, Vol.18 (6), p.908-914

1998

Volltextzugriff (PDF)

Protein kinase C and vascular smooth muscle contractility: effects of inhibitors and down-regulation

The Journal of pharmacology and experimental therapeutics, 1991-04, Vol.257 (1), p.134

1991

Volltextzugriff (PDF)

Pharmacodynamic Activity and Antithrombotic Efficacy of RPR120844, a Novel Inhibitor of Coagulation Factor Xa

Journal of cardiovascular pharmacology, 1999-12, Vol.34 (6), p.791-799

1999

Volltextzugriff (PDF)

Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery

Thrombosis and haemostasis, 1997-10, Vol.78 (4), p.1278-1285

1997

Volltextzugriff (PDF)

Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle

The Journal of pharmacology and experimental therapeutics, 1989-05, Vol.249 (2), p.394

1989

Volltextzugriff (PDF)

Differential Alteration of Vascular Reactivity in Rabbit Aorta With Modest Elevation of Serum Cholesterol

Circulation research, 1990-09, Vol.67 (3), p.550-555

1990

Volltextzugriff (PDF)

In vitro and in vivo characterization of an A1-selective adenosine agonist, RG14202

The Journal of pharmacology and experimental therapeutics, 1993-05, Vol.265 (2), p.699

1993

Volltextzugriff (PDF)

Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle

European journal of pharmacology, 1988-05, Vol.150 (1), p.85-94

1988

Volltextzugriff (PDF)

Antithrombotic efficacy of a novel factor Xa inhibitor, FXV673, in a canine model of coronary artery thrombolysis

British journal of pharmacology, 2001-08, Vol.133 (7), p.1190-1198

2001

Volltextzugriff (PDF)

Pharmacological analysis of alpha-2 adrenergic mechanisms in nociception and ataxia

The Journal of pharmacology and experimental therapeutics, 1985-03, Vol.232 (3), p.883

1985

Volltextzugriff (PDF)

Ischaemia/reperfusion selectively attenuates coronary vasodilatation to an adenosine A2‐ but not to an A1‐agonist in the dog

British journal of pharmacology, 1994-04, Vol.111 (4), p.1233-1239

1994

Volltextzugriff (PDF)

Inhibition of EGF-Induced Vasoconstriction in Isolated Rabbit Aortic Rings with the Tyrosine Kinase Inhibitor RG50864

Biochemical and biophysical research communications, 1993-05, Vol.192 (3), p.1319-1326

1993

Volltextzugriff (PDF)

Regional Hemodynamic Dose-Response of Lemakalim and Glybenclamide in Anesthetized Rats

Journal of cardiovascular pharmacology, 1997-01, Vol.29 (1), p.49-56

1997

Volltextzugriff (PDF)

Cardiovascular Pharmacology of the Adenosine A1/A2-Receptor Agonist AMP 579: Coronary Hemodynamic and Cardioprotective Effects in the Canine Myocardium

Journal of cardiovascular pharmacology, 1999-05, Vol.33 (5), p.703-710

1999

Volltextzugriff (PDF)

In vivo assessment of napamezole, an alpha-2 adrenoceptor antagonist and monoamine re-uptake inhibitor

The Journal of pharmacology and experimental therapeutics, 1990-08, Vol.254 (2), p.476

1990

Volltextzugriff (PDF)

1 – 25 von 407

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(353)
Mit Volltextzugriff
(347)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(267)
Life Sciences & Biomedicine
(216)
Humans
(129)
Male
(100)
Biological And Medical Sciences
(94)
Animals
(88)
Female
(77)
Medical Sciences
(76)
Rats
(49)
Physical Sciences
(46)
Cardiovascular System & Cardiology
(45)
Middle Aged
(45)
Pharmacology. Drug Treatments
(40)
Adult
(38)
Cardiac & Cardiovascular Systems
(32)
Aged
(31)
Pharmacology & Pharmacy
(29)
Physics
(25)
Astronomy & Astrophysics
(22)
Fundamental And Applied Biological Sciences. Psychology
(22)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin

Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis

Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction

Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels

Pharmacological Characterization of a Novel Factor Xa Inhibitor, FXV673

Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells

Identification and Initial Structure−Activity Relationships of a Novel Class of Nonpeptide Inhibitors of Blood Coagulation Factor Xa

RPR120844, a novel, specific inhibitor of coagulation factor Xa inhibits venous thrombosis in the rabbit

In Vitro Characterization of a Novel Factor Xa Inhibitor, RPR 130737

Characterization and inhibition of 15-lipoxygenase in human monocytes: comparison with soybean 15-lipoxygenase

Inhibition of repetitive thrombus formation in the stenosed canine coronary artery by enoxaparin, but not by unfractionated heparin

Protein kinase C and vascular smooth muscle contractility: effects of inhibitors and down-regulation

Pharmacodynamic Activity and Antithrombotic Efficacy of RPR120844, a Novel Inhibitor of Coagulation Factor Xa

Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery

Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle

Differential Alteration of Vascular Reactivity in Rabbit Aorta With Modest Elevation of Serum Cholesterol

In vitro and in vivo characterization of an A1-selective adenosine agonist, RG14202

Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle

Antithrombotic efficacy of a novel factor Xa inhibitor, FXV673, in a canine model of coronary artery thrombolysis

Pharmacological analysis of alpha-2 adrenergic mechanisms in nociception and ataxia

Ischaemia/reperfusion selectively attenuates coronary vasodilatation to an adenosine A2‐ but not to an A1‐agonist in the dog

Inhibition of EGF-Induced Vasoconstriction in Isolated Rabbit Aortic Rings with the Tyrosine Kinase Inhibitor RG50864

Regional Hemodynamic Dose-Response of Lemakalim and Glybenclamide in Anesthetized Rats

Cardiovascular Pharmacology of the Adenosine A1/A2-Receptor Agonist AMP 579: Coronary Hemodynamic and Cardioprotective Effects in the Canine Myocardium

In vivo assessment of napamezole, an alpha-2 adrenoceptor antagonist and monoamine re-uptake inhibitor

Suchergebnisse filtern